Obstructive Sleep Apnea Treatment on Cardiovascular Events in Patients With Acute Cardiogenic Pulmonary Edema: CPAP-CARE STUDY.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

PHASE4

Total Enrollment

150 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-04-01

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Despite the advances in the treatment of acute cardiogenic pulmonary edema (ACPE), the readmissions rates and cardiovascular events remain very high. In this context, it is possible that other potential risk factors may influence the poor prognosis of the ACPE. One of these potential candidates is Obstructive Sleep Apnea(OSA). This study was designed to evaluate the impact of OSA treatment with CPAP in consecutive patients with ACPE. The primary outcome will be to evaluate the impact of CPAP on the recurrence of ACPE in the 1-year follow-up.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Impact of Early Diagnosis and Treatment of OSA on Hospital Readmission in Hospitalized Cardiac Patients

NCT03647891

OSA Heart Failure Myocardial Infarction +1 more

SUSPENDED NA

Cardiovascular Impact of Obstructive Sleep Apnea Treatment in Normotensive Patients

NCT00741520

Obstructive Sleep Apnea

COMPLETED PHASE4

Continuous Positive Airway Pressure Treatment of Obstructive Sleep Apnea to Prevent Cardiovascular Disease

NCT00738179

Sleep Apnea Cardiovascular Disease

UNKNOWN PHASE3

Long Term Cardiovascular Complications in Men With Obstructive Sleep Apnea

NCT01475682

Obstructive Sleep Apnea Cardiovascular Diseases Metabolic Diseases

UNKNOWN

Sleep Apnea in Heart Failure With Preserved Ejection Fraction

NCT05008432

Heart Failure Obstructive Sleep Apnea

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obstructive Sleep Apnea Pulmonary Edema Cardiac Cause

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

CPAP

Continuous positive airway pressure

Group Type ACTIVE_COMPARATOR

CPAP

Intervention Type DEVICE

This is the standard treatment for OSA.

Nasal strips

Nasal Strips

Group Type SHAM_COMPARATOR

Nasal Strips

Intervention Type DEVICE

Nasal strips were commercially available in the market for supposing treat snoring and sleep apnea but no proof that this is true. Our group previously validated nasal strips as an interesting placebo.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

CPAP

This is the standard treatment for OSA.

Intervention Type DEVICE

Nasal Strips

Nasal strips were commercially available in the market for supposing treat snoring and sleep apnea but no proof that this is true. Our group previously validated nasal strips as an interesting placebo.

Intervention Type DEVICE